The Relationship Between Baseline Body Weight and Glycemic Control Following Metformin Extended-Release Tablets (Glucophage XR) Monotherapy in Chinese Patients With Newly Diagnosed Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2013
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 14 Apr 2011 Actual end date (1 Mar 2011) added as reported by ClinicalTrials.gov.
- 14 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2010 Planned end date changed from 1 Jan 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.